An O-prenylated benzylidene-thiazolidinedione derivative suppresses NF-κB signaling in a breast cancer cell line: Possible implications for therapy.
- DOI
- 10.1016/j.mrgentox.2026.503951
- Published
- 2026 Aug-Sep
- Container
- Mutation research. Genetic toxicology and environmental mutagenesis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mrgentox.2026.503951,
title = {An O-prenylated benzylidene-thiazolidinedione derivative suppresses NF-κB signaling in a breast cancer cell line: Possible implications for therapy.},
author = {Roy SS and Hajra S and Basu A and Bhattacharya S},
year = {2026},
journal = {Mutation research. Genetic toxicology and environmental mutagenesis},
doi = {10.1016/j.mrgentox.2026.503951},
url = {https://doi.org/10.1016/j.mrgentox.2026.503951}
}RIS
TY - JOUR TI - An O-prenylated benzylidene-thiazolidinedione derivative suppresses NF-κB signaling in a breast cancer cell line: Possible implications for therapy. AU - Roy SS AU - Hajra S AU - Basu A AU - Bhattacharya S PY - 2026 JO - Mutation research. Genetic toxicology and environmental mutagenesis DO - 10.1016/j.mrgentox.2026.503951 UR - https://doi.org/10.1016/j.mrgentox.2026.503951 ER -
APA
SS, R., S, H., A, B., & S, B. (2026). An O-prenylated benzylidene-thiazolidinedione derivative suppresses NF-κB signaling in a breast cancer cell line: Possible implications for therapy.. Mutation research. Genetic toxicology and environmental mutagenesis. https://doi.org/10.1016/j.mrgentox.2026.503951
Source records
- pubmed · retrieved 2026-09-25T23:31:56.324Z